Valacyclovir Maintenance Therapy for a Case of Unilateral Acute Retinal Necrosis during Chemotherapy
نویسندگان
چکیده
منابع مشابه
Valacyclovir in the treatment of acute retinal necrosis
BACKGROUND To report the outcome of oral valacyclovir as the sole antiviral therapy for patients with acute retinal necrosis (ARN). METHODS This study reports a retrospective, interventional case series of nine consecutive patients with ten eyes with newly diagnosed ARN treated with oral valacyclovir as the sole antiviral agent. Eight patients received oral valacyclovir 2 g tid (Valtrex, Glax...
متن کاملEfficacy of Oral Valacyclovir Treatment in a Case with Acute Retinal Necrosis
Acute retinal necrosis (ARN) is a rapidly progressive disease with poor prognosis, leading to visual loss in most cases. Rapid diagnosis and early anti-viral treatment significantly affect the course and prognosis of the disease. In this case report, we present a 34-year-old female patient referred to our clinic with symptoms of blurred vision and ocular pain diagnosed as acute glaucoma elsewhe...
متن کاملValacyclovir as a Therapeutic Agent in Acute Retinal Necrosis: Two Case Reports
Introduction: Acute retinal necrosis (ARN) is a rare, rapidly progressive viral retinitis. The current standard of care for ARN consists of intravenous acyclovir for 5-10 days, followed by oral acyclovir for an additional 6-12 weeks. Valacyclovir has superior plasma bioavailability to acyclovir as an oral preparation. The aim of this study is to add to the evidence of treating ARN with valacycl...
متن کاملa case of acute retinal necrosis following herpetic encephalitis
purpose: to report a case of acute retinal necrosis following herpetic encephalitis. case report: a 25-year-old male presented with pain and visual loss in his left eye. he had herpetic encephalitis 1 month prior to the visual symptoms. ophthalmologic examination and paraclinical evaluation disclosed acute retinal necrosis. conclusion: herpetic encephalitis may be a risk factor for acute retina...
متن کاملT Regulatory Cells Frequency During Maintenance Phase Chemotherapy for Pediatric Acute Lymphoblastic Leukemia
Background: Drugs used in cancer treatment specifically kill T regulatory cells. Objective: To determine different phenotypes of T regulatory cells during the maintenance phase chemotherapy for pediatric acute lymphoblastic leukemia (ALL). Materials: We evaluated the percentages of regulatory T cells by flow cytometry. Soluble CTLA-4 (sCTLA-4) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Kansenshogaku Zasshi
سال: 2017
ISSN: 0387-5911,1884-569X
DOI: 10.11150/kansenshogakuzasshi.91.159